Arch-clamping with mild hypothermia for acute Type A aortic dissection.
Official title: Arch-Clamping Technique Under Mild Hypothermia in Treating With Acute Type A Aortic Dissection: Study Protocol for a Multicenter, Three-arm, Open-label, Randomized, Parallel-controlled Trial
Run by Beijing Anzhen Hospital · NCT07150559 · Data updated 2026-11-12
This study will test whether using arch-clamping under mild hypothermia during total arch replacement with frozen elephant trunk reduces major complications in adults with acute Type A aortic dissection.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 70 Years |
| Sex | All |
| Enrollment | 306 (estimated) |
| Sponsor | Beijing Anzhen Hospital Academic / other |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Status | Recruiting |
| Started | February 3, 2026 |
| Main results expected | December 30, 2027 |
| Study ends | February 28, 2028 |
| Registry record updated | April 6, 2026 |
| Trial ID | NCT07150559 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–70 with CTA-confirmed acute Type A aortic dissection, weighing 50–120 kg, presenting within 14 days of symptom onset and eligible for total aortic arch replacement who can provide informed consent are ideal candidates.
✕Probably not a fit
Patients with chronic renal failure, severe liver disease, severe preoperative neurological compromise or intubation, inflammatory or infectious aortitis, prior cardiac/aortic surgery, or other excluded conditions are unlikely to benefit and are excluded.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a multicenter, randomized, open-label, three-arm parallel trial enrolling 306 patients with acute Type A aortic dissection across seven hospitals in China. All participants undergo total aortic arch replacement with frozen elephant trunk and are randomized 1:1:1 to arch-clamping under mild hypothermia, arch-clamping under moderate hypothermia, or Sun's procedure using bilateral antegrade cerebral perfusion under moderate hypothermic circulatory arrest. The trial compares the incidence of major adverse events (death, renal replacement therapy, stroke, paraplegia) and procedural measures including circulatory arrest time, cardiopulmonary bypass time, mechanical ventilation duration, and ICU length of stay. Participants are followed for one year to determine the safety and validity of the mild hypothermic arch-clamping technique.
Why it matters
Potential benefit: If successful, this approach could lower rates of death, stroke, and renal failure and shorten ICU and ventilation times after surgery for acute Type A aortic dissection.
How similar studies have gone: Cerebral protection strategies such as bilateral antegrade cerebral perfusion and Sun's procedure have supportive clinical experience, but randomized data specifically testing arch-clamping under mild hypothermia are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Aortic CTA confirmed as ATAAD according to the 2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease; 2. Adult patients (18-70 years) weighing 50-120 kg; 3. Time interval between the onset of symptoms and operation is less than 14 days; 4. Indications for total aortic arch replacement are available; 5. Signed informed consent and availability for follow-up. Exclusion Criteria: 1. History of chronic renal failure, hepatocirrhosis, and hepatic insufficiency; 2. Severe gastrointestinal complications of non-aortic dissection, such as mesenteric ischemia, gastrointestinal bleeding, hepatopancreaticobiliary dysfunction, and intestinal obstruction; 3. History of severe cerebral infarction (with cerebral infarction sequels); 4. Preoperative intubation or unconsciousness; 5. Inflammatory aortic diseases, such as Takayasu arteritis and Behçet's disease, etc; 6. History of infectious aortic diseases; 7. History of cardiac and aortic surgery; 8. History of malignancy or previous radiotherapy; 9. Pregnant or feeding women, or anyone planning to reproduce during the test period; 10. Without an informed consent signature; 11. Participating in any other clinical trial; 12. Having other causes not eligible for operation.
Where it's running
-
Beijing Anzhen Hospital
Beijing, Beijing Municipality, China Recruiting
Study contacts
- Study coordinator: Su-Wei Chen, Doctor
- Email: 15524612655@163.com
- Phone: +86 155 2461 2655
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Acupressure to reduce feverish shivering after cesarean delivery
This study tests whether applying acupressure around the time of cesarean delivery can help prevent hypothermia and shivering in healthy-looking, first-time cesarean patients.
-
Easy external landmarks to guide correct esophageal probe placement
This study will test whether simple external body landmarks can reliably tell clinicians how far to insert an esophageal temperature probe in adult ICU patients undergoing TEE.
-
Effect of early nasal cooling on survival after cardiac arrest
This study is testing if cooling patients right after a cardiac arrest can help them survive better and recover their brain function compared to standard care.
-
Using a blood warmer to prevent hypothermia in preterm infants during blood transfusions
This study is testing if using a blood warmer during blood transfusions can help very preterm infants stay warm and avoid hypothermia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.